Evidence map›Paper›PMID 39076348›Full record

ArticleBhutan health journal2020

Is Leishmaniasis donovani elimination feasible in Bhutan? A review of current prevention and control mechanisms in Bhutan.

Tashi Tobgay, Sithar Dorjee, Ambika Pradhan, Tenzin Wangdi, Tobgye Drukpa, Rinxin Namgye, Guofa Zhou, Nadira D Karunaweera

Abstract read
In one paragraph

Article in Bhutan health journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tashi TobgayKhesar Gyalpo University of Medical Sciences of Bhutan, Thimphu, Bhutan.
Sithar DorjeeKhesar Gyalpo University of Medical Sciences of Bhutan, Thimphu, Bhutan.
Ambika PradhanJigme Dorji Wangchuck National Referral Hospital, Thimphu, Bhutann.
Tenzin WangdiVector Borne Disease Control Program, Gelephu, Bhutan.
Tobgye DrukpaVector Borne Disease Control Program, Gelephu, Bhutan.
Rinxin NamgyeVector Borne Disease Control Program, Gelephu, Bhutan.
Guofa ZhouProgram in Public Health, University of California, Irvine, CA, USA.
Nadira D KarunaweeraDepartment of Parasitology, Faculty of Medicine, University of Colombo, Sri Lanka.

Funding

Epidemiology and transmission of Leishmania donovani infections in Sri Lanka and BhutanU01AI136033 · NIAID · UNIVERSITY OF COLOMBO · PI KARUNAWEERA, NADIRA DHARSHANI, ZHOU, GUOFA · 2017 to 2021
$2.0M
NIAID NIH HHS U01 AI136033
6 · The paper itself

Abstract

Leishmaniasis is a neglected tropical disease with an annual estimated 700,000 to 1 million new cases globally. The diseases affect the rural community and people living in poverty. It is transmitted by female phlebotomine sand-fly; a tiny 2-3 mm long insect vector. Along with the regional countries, Bhutan has embarked on the elimination goal. However, several challenges lies ahead on its path to elimination. There is no elimination strategy and actions. The reporting, surveillance system, control and prevention mechanisms are inadequate. Further, there is lack of knowledge among the health care providers that impedes elimination goals. Therefore, if Bhutan is serious about its elimination goal, all the gaps and current challenges needs to be addressed appropriately.

Indexed as

BhutanEliminationLeishmaniasis

Identifiers

PMID39076348
PMCPMC11286285

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.